Milia en plaque on the shoulder as an early manifestations of mycosis fungoides
Milia en plaque (MEP) is an uncommon skin condition identified as retroauricular confluent milium by Boulzer and Fouqet in 1903 [1]. It can be mistaken for other dermatoses like Favre-Racouchot nodular elastosis, steatocystoma multiplex, and nevus comedonicus. Milia en plaque can either be primary or secondary and is typically benign, often triggered by dermatological procedures like cryotherapy, as reported in this journal. In some cases, MEP can arise as a secondary manifestation of other diseases, including folliculotropic mycosis fungoides (FMF). Despite this association, there are few documented cases in the literatur...
Source: Dermatology Online Journal - March 12, 2024 Category: Dermatology Authors: Rodrigues, Felipe Tavares Source Type: research

Mycosis fungoides-like eruptions associated with abatacept
Australas J Dermatol. 2024 Mar 7. doi: 10.1111/ajd.14249. Online ahead of print.NO ABSTRACTPMID:38454790 | DOI:10.1111/ajd.14249 (Source: The Australasian Journal of Dermatology)
Source: The Australasian Journal of Dermatology - March 8, 2024 Category: Dermatology Authors: Daichi Hoshina Yuri Nagata Source Type: research

Mycosis fungoides-like eruptions associated with abatacept
Australas J Dermatol. 2024 Mar 7. doi: 10.1111/ajd.14249. Online ahead of print.NO ABSTRACTPMID:38454790 | DOI:10.1111/ajd.14249 (Source: The Australasian Journal of Dermatology)
Source: The Australasian Journal of Dermatology - March 8, 2024 Category: Dermatology Authors: Daichi Hoshina Yuri Nagata Source Type: research

Mycosis fungoides-like eruptions associated with abatacept
Australas J Dermatol. 2024 Mar 7. doi: 10.1111/ajd.14249. Online ahead of print.NO ABSTRACTPMID:38454790 | DOI:10.1111/ajd.14249 (Source: The Australasian Journal of Dermatology)
Source: The Australasian Journal of Dermatology - March 8, 2024 Category: Dermatology Authors: Daichi Hoshina Yuri Nagata Source Type: research

Mycosis fungoides-like eruptions associated with abatacept
Australas J Dermatol. 2024 Mar 7. doi: 10.1111/ajd.14249. Online ahead of print.NO ABSTRACTPMID:38454790 | DOI:10.1111/ajd.14249 (Source: The Australasian Journal of Dermatology)
Source: The Australasian Journal of Dermatology - March 8, 2024 Category: Dermatology Authors: Daichi Hoshina Yuri Nagata Source Type: research

Mycosis fungoides-like eruptions associated with abatacept
Australas J Dermatol. 2024 Mar 7. doi: 10.1111/ajd.14249. Online ahead of print.NO ABSTRACTPMID:38454790 | DOI:10.1111/ajd.14249 (Source: The Australasian Journal of Dermatology)
Source: The Australasian Journal of Dermatology - March 8, 2024 Category: Dermatology Authors: Daichi Hoshina Yuri Nagata Source Type: research

Immunobiology and treatment of cutaneous T-cell lymphoma
Expert Rev Clin Immunol. 2024 Mar 7:1-12. doi: 10.1080/1744666X.2024.2326035. Online ahead of print.ABSTRACTINTRODUCTION: Primary cutaneous T cell lymphomas (CTCL) are a heterogenous group of non-Hodgkin lymphomas derived from skin-homing T cells. These include mycosis fungoides and its leukemic variant Sezary syndrome, as well as the CD30+ lymphoproliferative disorders.AREAS COVERED: In this review, we provide a summary of the current literature on CTCL, with a focus on the immunopathogenesis and treatment of mycosis fungoides and Sezary syndrome.EXPERT OPINION: Recent advances in immunology have provided new insights int...
Source: Expert Review of Clinical Immunology - March 7, 2024 Category: Allergy & Immunology Authors: Rishi R Goel Alain H Rook Source Type: research

Predictive and prognostic biomarkers in patients with Mycosis fungoides and S ézary syndrome (BIO-MUSE): Study protocol for a translational study
CONCLUSIONS: The study aims to investigate blood and skin with focus on immune cells and the microbiological environment to identify potential new prognostic biomarkers in MF and SS.CLINICALTRIAL: Clinicaltrials.gov NCT04904146.PMID:38436589 | DOI:10.2196/55723 (Source: Cell Research)
Source: Cell Research - March 4, 2024 Category: Cytology Authors: Emma Belfrage Sara Ek Åsa Johansson Hanna Brauner Andreas Sonesson Kristina Drott Source Type: research

Cutaneous T-Cell Lymphoma and Microbiota: Etiopathogenesis and Potential New Therapeutic Targets
CONCLUSION: There appears to be a relationship between cutaneous T-cell lymphoma and the cutaneous and intestinal microbiome, as well as a possible pathophysiological pathway involved. The possible modulation of the cutaneous and intestinal microbiome or the action on the signaling inflammatory pathway, using pharmacological tools such as JAK inhibitors or IL-17 inhibitors in the latter case, could open the possibility for future therapeutic studies for cutaneous T-cell lymphoma.PMID:38435536 | PMC:PMC10904680 | DOI:10.1155/2024/9919225 (Source: Cell Research)
Source: Cell Research - March 4, 2024 Category: Cytology Authors: Daniel Rodr íguez Baeza L ía Bejarano Antonio Marta Gonz ález de Arriba Jos é Antonio Picó-Monllor Javier Ca ñueto Vicente Navarro-Lopez Source Type: research

Cutaneous T-Cell Lymphoma and Microbiota: Etiopathogenesis and Potential New Therapeutic Targets
CONCLUSION: There appears to be a relationship between cutaneous T-cell lymphoma and the cutaneous and intestinal microbiome, as well as a possible pathophysiological pathway involved. The possible modulation of the cutaneous and intestinal microbiome or the action on the signaling inflammatory pathway, using pharmacological tools such as JAK inhibitors or IL-17 inhibitors in the latter case, could open the possibility for future therapeutic studies for cutaneous T-cell lymphoma.PMID:38435536 | PMC:PMC10904680 | DOI:10.1155/2024/9919225 (Source: Dermatology Research and Practice)
Source: Dermatology Research and Practice - March 4, 2024 Category: Dermatology Authors: Daniel Rodr íguez Baeza L ía Bejarano Antonio Marta Gonz ález de Arriba Jos é Antonio Picó-Monllor Javier Ca ñueto Vicente Navarro-Lopez Source Type: research